Does the media favor COO or XRAY?

In the previous week, Cooper Companies had 7 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 10 mentions for Cooper Companies and 3 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.39 beat DENTSPLY SIRONA's score of 0.25 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 3 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral DENTSPLY SIRONA 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer MMSI or XRAY?

In the previous week, Merit Medical Systems had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 5 mentions for Merit Medical Systems and 3 mentions for DENTSPLY SIRONA. Merit Medical Systems' average media sentiment score of 1.07 beat DENTSPLY SIRONA's score of 0.25 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DENTSPLY SIRONA 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor XRAY or NVST?

In the previous week, DENTSPLY SIRONA had 1 more articles in the media than Envista. MarketBeat recorded 3 mentions for DENTSPLY SIRONA and 2 mentions for Envista. Envista's average media sentiment score of 0.77 beat DENTSPLY SIRONA's score of 0.25 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor XRAY or ICUI?

In the previous week, DENTSPLY SIRONA and DENTSPLY SIRONA both had 3 articles in the media. ICU Medical's average media sentiment score of 1.22 beat DENTSPLY SIRONA's score of 0.25 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ICU Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

DENTSPLY SIRONA (XRAY) Competitors

$11.65 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$11.66 +0.01 (+0.13%)

As of 07/2/2026 07:56 PM Eastern

Compare

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

Should you buy DENTSPLY SIRONA stock or one of its competitors? MarketBeat compares DENTSPLY SIRONA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with DENTSPLY SIRONA include Cooper Companies (COO), Merit Medical Systems (MMSI), Envista (NVST), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "medical" sector.

How does DENTSPLY SIRONA compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

Cooper Companies has a net margin of 5.57% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Cooper Companies currently has a consensus price target of $81.31, suggesting a potential upside of 9.58%. DENTSPLY SIRONA has a consensus price target of $13.55, suggesting a potential upside of 16.27%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.38
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cooper Companies has higher revenue and earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.54	$374.90M	$1.18	62.88
DENTSPLY SIRONA	$3.68B	0.63	-$598M	-$3.15	N/A

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cooper Companies has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

In the previous week, Cooper Companies had 7 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 10 mentions for Cooper Companies and 3 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.39 beat DENTSPLY SIRONA's score of 0.25 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	3 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cooper Companies beats DENTSPLY SIRONA on 13 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

Merit Medical Systems currently has a consensus price target of $92.80, suggesting a potential upside of 30.54%. DENTSPLY SIRONA has a consensus price target of $13.55, suggesting a potential upside of 16.27%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, research analysts clearly believe Merit Medical Systems is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Merit Medical Systems had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 5 mentions for Merit Medical Systems and 3 mentions for DENTSPLY SIRONA. Merit Medical Systems' average media sentiment score of 1.07 beat DENTSPLY SIRONA's score of 0.25 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Merit Medical Systems has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.54B	2.75	$128.49M	$2.31	30.77
DENTSPLY SIRONA	$3.68B	0.63	-$598M	-$3.15	N/A

Merit Medical Systems has a net margin of 9.03% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Merit Medical Systems has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 13 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Envista?

DENTSPLY SIRONA (NASDAQ:XRAY) and Envista (NYSE:NVST) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

In the previous week, DENTSPLY SIRONA had 1 more articles in the media than Envista. MarketBeat recorded 3 mentions for DENTSPLY SIRONA and 2 mentions for Envista. Envista's average media sentiment score of 0.77 beat DENTSPLY SIRONA's score of 0.25 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envista	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DENTSPLY SIRONA presently has a consensus target price of $13.55, suggesting a potential upside of 16.27%. Envista has a consensus target price of $28.67, suggesting a potential upside of 3.92%. Given DENTSPLY SIRONA's higher probable upside, equities analysts plainly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
Envista	2.41%	7.11%	3.91%

DENTSPLY SIRONA has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Envista has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.63	-$598M	-$3.15	N/A
Envista	$2.72B	1.65	$47M	$0.41	67.28

Summary

Envista beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to ICU Medical?

DENTSPLY SIRONA (NASDAQ:XRAY) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

DENTSPLY SIRONA has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

ICU Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.63	-$598M	-$3.15	N/A
ICU Medical	$2.23B	1.74	$730K	$1.85	83.77

In the previous week, DENTSPLY SIRONA and DENTSPLY SIRONA both had 3 articles in the media. ICU Medical's average media sentiment score of 1.22 beat DENTSPLY SIRONA's score of 0.25 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ICU Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA currently has a consensus target price of $13.55, indicating a potential upside of 16.27%. ICU Medical has a consensus target price of $168.40, indicating a potential upside of 8.67%. Given DENTSPLY SIRONA's higher probable upside, equities research analysts plainly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	3 Strong Buy rating(s)	3.00

ICU Medical has a net margin of 2.15% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
ICU Medical	2.15%	7.50%	3.91%

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by company insiders. Comparatively, 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

ICU Medical beats DENTSPLY SIRONA on 11 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Haemonetics?

DENTSPLY SIRONA (NASDAQ:XRAY) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

DENTSPLY SIRONA has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Haemonetics has a net margin of 7.29% compared to DENTSPLY SIRONA's net margin of -17.06%. Haemonetics' return on equity of 27.30% beat DENTSPLY SIRONA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
Haemonetics	7.29%	27.30%	9.59%

DENTSPLY SIRONA presently has a consensus price target of $13.55, suggesting a potential upside of 16.27%. Haemonetics has a consensus price target of $78.33, suggesting a potential upside of 4.54%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Haemonetics has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.63	-$598M	-$3.15	N/A
Haemonetics	$1.33B	2.55	$97.31M	$2.02	37.09

In the previous week, DENTSPLY SIRONA had 3 more articles in the media than Haemonetics. MarketBeat recorded 3 mentions for DENTSPLY SIRONA and 0 mentions for Haemonetics. DENTSPLY SIRONA's average media sentiment score of 0.25 beat Haemonetics' score of -1.00 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company	Overall Sentiment
DENTSPLY SIRONA	Neutral
Haemonetics	Negative

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 2.1% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Haemonetics beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XRAY vs. The Competition

Export

Metric	DENTSPLY SIRONA	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.33B	$17.82B	$7.18B	$12.47B
Dividend Yield	N/A	1.31%	2.66%	6.50%
P/E Ratio	-3.70	19.34	28.02	24.70
Price / Sales	0.63	2.41	532.59	97.92
Price / Cash	1.94	14.43	49.26	57.09
Price / Book	1.73	3.38	10.96	6.46
Net Income	-$598M	$534.24M	$3.57B	$337.01M
7 Day Performance	5.81%	0.75%	2.12%	1.69%
1 Month Performance	16.50%	3.67%	5.25%	3.81%
1 Year Performance	-29.54%	1.28%	33.29%	23.90%

DENTSPLY SIRONA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XRAY DENTSPLY SIRONA	4.1792 of 5 stars	$11.65 flat	$13.55 +16.3%	-29.5%	$2.33B	$3.68B	N/A	14,000	Gap Down
COO Cooper Companies	2.6177 of 5 stars	$71.39 +0.5%	$81.31 +13.9%	+1.6%	$13.85B	$4.09B	60.50	15,000
MMSI Merit Medical Systems	4.3574 of 5 stars	$70.09 -2.3%	$92.80 +32.4%	-24.0%	$4.28B	$1.52B	30.34	7,500	News Coverage Positive News
NVST Envista	1.5223 of 5 stars	$26.97 +0.0%	$28.67 +6.3%	+35.3%	$4.39B	$2.72B	65.78	12,000	News Coverage
ICUI ICU Medical	3.4658 of 5 stars	$147.93 -0.2%	$168.40 +13.8%	+14.4%	$3.71B	$2.23B	79.96	13,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XRAY) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

How does DENTSPLY SIRONA compare to Cooper Companies?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Summary

How does DENTSPLY SIRONA compare to Envista?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Summary

How does DENTSPLY SIRONA compare to Haemonetics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

How does DENTSPLY SIRONA compare to Cooper Companies?

Is COO or XRAY more profitable?

Do analysts rate COO or XRAY?

Which has better valuation & earnings, COO or XRAY?

Do insiders and institutionals hold more shares of COO or XRAY?

Which has more risk and volatility, COO or XRAY?

Does the media favor COO or XRAY?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Do analysts prefer MMSI or XRAY?

Does the media prefer MMSI or XRAY?

Which has preferable valuation & earnings, MMSI or XRAY?

Is MMSI or XRAY more profitable?

Do institutionals and insiders hold more shares of MMSI or XRAY?

Which has more volatility and risk, MMSI or XRAY?

Summary

How does DENTSPLY SIRONA compare to Envista?

Does the media favor XRAY or NVST?

Do insiders and institutionals hold more shares of XRAY or NVST?

Do analysts rate XRAY or NVST?

Is XRAY or NVST more profitable?

Which has more risk & volatility, XRAY or NVST?

Which has higher earnings & valuation, XRAY or NVST?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Which has more risk and volatility, XRAY or ICUI?

Which has stronger earnings & valuation, XRAY or ICUI?

Does the media favor XRAY or ICUI?

Do analysts rate XRAY or ICUI?

Is XRAY or ICUI more profitable?

Do insiders & institutionals believe in XRAY or ICUI?

Summary

How does DENTSPLY SIRONA compare to Haemonetics?

Which has more risk & volatility, XRAY or HAE?

Is XRAY or HAE more profitable?

Do analysts recommend XRAY or HAE?

Which has preferable earnings and valuation, XRAY or HAE?

Does the media favor XRAY or HAE?

Do institutionals & insiders have more ownership in XRAY or HAE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools